Latest News for: 003

Edit

December 24, 2025 KASE Index increased by 0.31% to 7,003.88 (KASE - Kazakhstan Stock Exchange JSC)

Public Technologies 24 Dec 2025
) December 24, 2025 KASE Index increased by 0.31% to 7,003.88. /KASE, December 24, 2025/ - By shares trading results on Kazakhstan Stock Exchange (KASE) on December 24, 2025, KASE Index increased by 21.74 points (0.31%) from 6,982.14 to 7,003.88.
Edit

Legal Notice: Multi Lake Water and Sewer Authority Resolution #2025-003

The Sun Times News 23 Dec 2025
MULTI LAKE WATER AND SEWER ...
Edit

Ukraine says received 1,003 bodies from Russia

Eye Witness News 19 Dec 2025
.
Edit

GUILD WARS 2 HC RUN FROM ZERO 003 WITH UI OFF / DEATH COUNTER ON 004

Rumble 19 Dec 2025
Click the Rumble article link to see the video ....
Edit

🔴 XAUUSD LIVE TRADING $1,003,000 Profit Forex Trading Live

Rumble 16 Dec 2025
Click the Rumble article link to see the video ....
Edit

Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) ...

Nasdaq Globe Newswire 15 Dec 2025
THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) WITH THE FOOD AND DRUG ADMINISTRATION (FDA) IN H1 2026 ... .
Edit

Kalpataru Projects International bags orders worth Rs 2,003 crore

The Times of India 10 Dec 2025
... Ltd (KPIL) announced securing new orders totaling approximately Rs 2,003 crore.
Edit

Kalpataru Projects International bags new orders worth ₹2,003 crore

Business Line 10 Dec 2025
The new orders are in the ...
Edit

Listing of the MZJ29NF1 mortgage bond, tranche number 003 (MBH Mortgage Bank Co plc)

Public Technologies 10 Dec 2025
). The Budapest Stock Exchange Plc ... Plc. (1117 Budapest, Magyar Tudósok körútja 9. G ép.) and modifies the Product List as of December 11, 2025 as follows. Old data New data. Number of securities listed. 1,449,500. 2,288,000 ... Budapest, December 10, 2025.
Edit

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium (Form 6-K) (Immutep Ltd)

Public Technologies 03 Dec 2025
Immutep to Present New Data from AIPAC-003 Phase II at ... AIPAC-003 has resulted in successful completion of FDA's Project Optimus requirements and selection of 30 mg as efti's optimal biological dose.
Edit

Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 ...

The Galveston Daily News 02 Dec 2025
PARIS--(BUSINESS WIRE)--Dec 2, 2025-- ....
Edit

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast ...

Nasdaq Globe Newswire 02 Dec 2025
IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company ...
Edit

Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis

Pharmiweb 02 Dec 2025
EGL-003’s Treg-selective design may also support expansion into additional autoimmune diseases where durable immune recalibration is needed ... About EGL-003. EGL-003 is a next-generation IL-2 mutein ...
Edit

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium (Immutep Ltd)

Public Technologies 02 Dec 2025
) Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium ... The AIPAC-003 trial has resulted in the successful completion of the FDA's Project Optimus ...
Edit

Bloomington vs Normal Community gallery 003 112525.JPG

The Pantagraph 26 Nov 2025
Bloomington vs. Normal Community on Tuesday, Nov. 25, 2025, during Intercity tournament at Shirk Center ... .

Article Search

tools
×
×
×
×